公开(公告)号：US5468465A

公开(公告)日：1995-11-21

申请号：US271921

申请日：1994-07-06

申请人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet B. Wilking ,  Linda Meeh ,  Steven R. Woulfe

发明人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet B. Wilking ,  Linda Meeh ,  Steven R. Woulfe

IPC分类号： A61B5/055 ,  A61B19/00 ,  A61K47/48 ,  A61K49/00 ,  A61K49/04 ,  A61K49/18 ,  A61K49/22 ,  C01B25/32 ,  C01G28/00 ,  C01G31/00 ,  C01G45/00 ,  C07F9/38

CPC分类号： A61K49/225 ,  A61K47/48861 ,  A61K49/1818 ,  A61K49/183 ,  A61K49/1842 ,  A61K49/1881 ,  A61B2090/3925 ,  A61B2090/3954 ,  A61B90/39 ,  Y10S977/722 ,  Y10S977/775 ,  Y10S977/881 ,  Y10S977/91 ,  Y10S977/927 ,  Y10S977/928 ,  Y10S977/929 ,  Y10S977/93 ,  Y10T436/24

摘要： Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging (37 MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for .sup.19 F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the abovedescribed apatite particles and then performing the medical diagnostic procedure.

摘要翻译： 公开了治疗磷灰石颗粒，用于增强诸如磁共振成像（“MRI”），磁共振光谱学（“MRS”），磁共振光谱成像（37MRSI“），X射线诊断成像和超声成像的医学诊断成像。 公开了新颖的涂层和制造技术来控制颗粒尺寸和颗粒聚集，从而获得用于肝脏，脾脏，胃肠道或组织疾病状态的器官特异性成像的组合物。根据诊断成像技术，将磷灰石颗粒处理为 磷灰石颗粒也可以被氟化以形成用于19F成像的稳定的氟磷灰石组合物。还公开了执行医学诊断程序的诊断组合物和方法，其涉及向温血动物施用诊断有效量的 上述磷灰石颗粒，然后执行药物 诊断程序。

公开(公告)号：US5609850A

公开(公告)日：1997-03-11

申请号：US518124

申请日：1995-08-22

申请人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet B. Wilking ,  Linda Meeh ,  Steven R. Woulfe

发明人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet B. Wilking ,  Linda Meeh ,  Steven R. Woulfe

IPC分类号： A61B5/055 ,  A61B19/00 ,  A61K47/48 ,  A61K49/00 ,  A61K49/04 ,  A61K49/18 ,  A61K49/22 ,  C01B25/32 ,  C01G28/00 ,  C01G31/00 ,  C01G45/00 ,  C07F9/38 ,  A61B8/13

CPC分类号： A61K49/225 ,  A61K47/48861 ,  A61K49/1818 ,  A61K49/183 ,  A61K49/1842 ,  A61K49/1881 ,  A61B2090/3925 ,  A61B2090/3954 ,  A61B90/39 ,  Y10S977/722 ,  Y10S977/775 ,  Y10S977/881 ,  Y10S977/91 ,  Y10S977/927 ,  Y10S977/928 ,  Y10S977/929 ,  Y10S977/93 ,  Y10T436/24

摘要： Treated apatite particles are disclosed for enhancing radical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging ("MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for .sup.19 F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the abovedescribed apatite particles and then performing the medical diagnostic procedure.

摘要翻译： 公开了处理的磷灰石颗粒，用于增强诸如磁共振成像（“MRI”），磁共振光谱（“MRS”），磁共振光谱成像（“MRSI”），X射线诊断成像和超声成像的基础诊断成像。 公开了新颖的涂层和制造技术来控制颗粒尺寸和颗粒聚集，从而获得用于肝脏，脾脏，胃肠道或组织疾病状态的器官特异性成像的组合物。 根据诊断成像技术，磷灰石颗粒被治疗为顺磁性，不透射线或回声。 磷灰石颗粒也可以被氟化以形成用于19F成像的稳定的氟磷灰石组合物。 还公开了执行医学诊断程序的诊断组合物和方法，其涉及向温血动物施用诊断有效量的上述磷灰石颗粒，然后执行医学诊断程序。

公开(公告)号：US5595724A

公开(公告)日：1997-01-21

申请号：US373152

申请日：1995-01-13

申请人： Edward A. Deutsch ,  Karen F. Deutsch ,  Dennis L. Nosco ,  William H. Ralston ,  David H. White ,  Janet B. Wilking ,  Robert G. Wolfangel ,  Steven R. Woulfe ,  William P. Cacheris ,  Linda Meeh

发明人： Edward A. Deutsch ,  Karen F. Deutsch ,  Dennis L. Nosco ,  William H. Ralston ,  David H. White ,  Janet B. Wilking ,  Robert G. Wolfangel ,  Steven R. Woulfe ,  William P. Cacheris ,  Linda Meeh

IPC分类号： A61B5/055 ,  A61B8/00 ,  A61B19/00 ,  A61K47/48 ,  A61K49/00 ,  A61K49/04 ,  A61K49/18 ,  A61K49/22 ,  A61K51/00 ,  A61K51/12 ,  C01B25/32 ,  C01G28/00 ,  C01G31/00 ,  C01G45/00 ,  C07F9/38 ,  G01R33/28

CPC分类号： A61K51/1241 ,  A61K47/48861 ,  A61K49/0414 ,  A61K49/1818 ,  A61K49/1842 ,  A61K49/1878 ,  A61K49/1881 ,  A61K49/225 ,  A61B2090/3925 ,  A61B2090/3954 ,  A61B90/39 ,  G01R33/281 ,  Y10S977/722 ,  Y10S977/881 ,  Y10S977/927 ,  Y10S977/928 ,  Y10S977/929 ,  Y10S977/93 ,  Y10T436/24

摘要： Treated calcium/oxyanion-containing particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging ("MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, or tissue disease states is obtained. Depending on the diagnostic imaging technique, calcium/oxyanion-containing particles are treated to be paramagnetic, radiopaque, or echogenic. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the above-described particles and then performing the medical diagnostic procedure.

摘要翻译： 公开了用于增强医学诊断成像例如磁共振成像（“MRI”），磁共振光谱（“MRS”），磁共振光谱成像（“MRSI”），X射线诊断成像， 和超声成像。 公开了新颖的涂层和制造技术来控制颗粒尺寸和颗粒聚集，从而获得用于肝脏，脾脏或组织疾病状态的器官特异性成像的组合物。 根据诊断成像技术，含钙/含氧阴离子的颗粒被处理为顺磁性，不透射线的或回声的。 还公开了执行医学诊断程序的诊断组合物和方法，其涉及向温血动物施用诊断有效量的上述颗粒，然后进行医学诊断程序。

公开(公告)号：US5344640A

公开(公告)日：1994-09-06

申请号：US948540

申请日：1992-09-22

申请人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet B. Wilking ,  Linda Meeh ,  Steven R. Woulfe

发明人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet B. Wilking ,  Linda Meeh ,  Steven R. Woulfe

IPC分类号： A61B5/055 ,  A61B19/00 ,  A61K47/48 ,  A61K49/00 ,  A61K49/04 ,  A61K49/18 ,  A61K49/22 ,  C01B25/32 ,  C01G28/00 ,  C01G31/00 ,  C01G45/00 ,  C07F9/38

CPC分类号： A61K49/225 ,  A61K47/48861 ,  A61K49/1818 ,  A61K49/183 ,  A61K49/1842 ,  A61K49/1881 ,  A61B2090/3925 ,  A61B2090/3954 ,  A61B90/39 ,  Y10S977/722 ,  Y10S977/775 ,  Y10S977/881 ,  Y10S977/91 ,  Y10S977/927 ,  Y10S977/928 ,  Y10S977/929 ,  Y10S977/93 ,  Y10T436/24

摘要： Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging ("MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for .sup.19 F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the above-described apatite particles and then performing the medical diagnostic procedure.

摘要翻译： 公开了治疗磷灰石颗粒用于增强诸如磁共振成像（“MRI”），磁共振光谱（“MRS”），磁共振光谱成像（“MRSI”），X射线诊断成像和超声成像的医学诊断成像。 公开了新颖的涂层和制造技术来控制颗粒尺寸和颗粒聚集，从而获得用于肝脏，脾脏，胃肠道或组织疾病状态的器官特异性成像的组合物。 根据诊断成像技术，磷灰石颗粒被治疗为顺磁性，不透射线或回声。 磷灰石颗粒也可以被氟化以形成用于19F成像的稳定的氟磷灰石组合物。 还公开了执行医学诊断程序的诊断组合物和方法，其涉及向温血动物施用诊断有效量的上述磷灰石颗粒，然后进行医学诊断程序。

公开(公告)号：US5690908A

公开(公告)日：1997-11-25

申请号：US557759

申请日：1995-11-13

申请人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet Braddock Wilking ,  Linda Meeh ,  Steven R. Woulfe

发明人： Edward A. Deutsch ,  Karen F. Deutsch ,  William P. Cacheris ,  William H. Ralston ,  David H. White ,  Dennis L. Nosco ,  Robert G. Wolfangel ,  Janet Braddock Wilking ,  Linda Meeh ,  Steven R. Woulfe

IPC分类号： A61B5/055 ,  A61B19/00 ,  A61K47/48 ,  A61K49/00 ,  A61K49/04 ,  A61K49/18 ,  A61K49/22 ,  C01B25/32 ,  C01G28/00 ,  C01G31/00 ,  C01G45/00 ,  C07F9/38

CPC分类号： A61K49/225 ,  A61K47/48861 ,  A61K49/1818 ,  A61K49/183 ,  A61K49/1842 ,  A61K49/1881 ,  A61B2090/3925 ,  A61B2090/3954 ,  A61B90/39 ,  Y10S977/722 ,  Y10S977/775 ,  Y10S977/881 ,  Y10S977/91 ,  Y10S977/927 ,  Y10S977/928 ,  Y10S977/929 ,  Y10S977/93 ,  Y10T436/24

摘要： Treated apatite particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging ("MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, gastrointestinal tract, or tissue disease states is obtained. Depending on the diagnostic imaging technique, apatite particles are treated to be paramagnetic, radiopaque, or echogenic. The apatite particles may also be fluorinated to form stable fluoroapatite compositions useful for .sup.19 F imaging. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the above-described apatite particles and then performing the medical diagnostic procedure.

摘要翻译： 公开了治疗磷灰石颗粒用于增强诸如磁共振成像（“MRI”），磁共振光谱（“MRS”），磁共振光谱成像（“MRSI”），X射线诊断成像和超声成像的医学诊断成像。 公开了新颖的涂层和制造技术来控制颗粒尺寸和颗粒聚集，从而获得用于肝脏，脾脏，胃肠道或组织疾病状态的器官特异性成像的组合物。 根据诊断成像技术，磷灰石颗粒被治疗为顺磁性，不透射线或回声。 磷灰石颗粒也可以被氟化以形成用于19F成像的稳定的氟磷灰石组合物。 还公开了执行医学诊断程序的诊断组合物和方法，其涉及向温血动物施用诊断有效量的上述磷灰石颗粒，然后进行医学诊断程序。

公开(公告)号：US5407659A

公开(公告)日：1995-04-18

申请号：US47129

申请日：1993-04-13

申请人： Edward A. Deutsch ,  Karen F. Deutsch ,  Dennis L. Nosco ,  William H. Ralston ,  David H. White ,  Janet B. Wilking ,  Robert G. Wolfangel ,  Steven R. Woulfe

发明人： Edward A. Deutsch ,  Karen F. Deutsch ,  Dennis L. Nosco ,  William H. Ralston ,  David H. White ,  Janet B. Wilking ,  Robert G. Wolfangel ,  Steven R. Woulfe

IPC分类号： A61B5/055 ,  A61B8/00 ,  A61B19/00 ,  A61K47/48 ,  A61K49/00 ,  A61K49/04 ,  A61K49/18 ,  A61K49/22 ,  A61K51/00 ,  A61K51/12 ,  C01B25/32 ,  C01G28/00 ,  C01G31/00 ,  C01G45/00 ,  C07F9/38 ,  G01R33/28

CPC分类号： A61K51/1241 ,  A61K47/48861 ,  A61K49/0414 ,  A61K49/1818 ,  A61K49/1842 ,  A61K49/1878 ,  A61K49/1881 ,  A61K49/225 ,  A61B2090/3925 ,  A61B2090/3954 ,  A61B90/39 ,  G01R33/281 ,  Y10S977/722 ,  Y10S977/881 ,  Y10S977/927 ,  Y10S977/928 ,  Y10S977/929 ,  Y10S977/93 ,  Y10T436/24

摘要： Treated calcium/oxyanion-containing particles are disclosed for enhancing medical diagnostic imaging such as magnetic resonance imaging ("MRI"), magnetic resonance spectroscopy ("MRS"), magnetic resonance spectroscopy imaging ("MRSI"), X-ray diagnostic imaging, and ultrasound imaging. Novel coating and manufacturing techniques are disclosed to control particle size and particle aggregation resulting in compositions for organ specific imaging of the liver, spleen, or tissue disease states is obtained. Depending on the diagnostic imaging technique, calcium/oxyanion-containing particles are treated to be paramagnetic, radiopaque, or echogenic. Also disclosed are diagnostic compositions and methods of performing medical diagnostic procedures which involve administering to a warm-blooded animal a diagnostically effective amount of the above-described particles and then performing the medical diagnostic procedure.

摘要翻译： 公开了用于增强医学诊断成像例如磁共振成像（“MRI”），磁共振光谱（“MRS”），磁共振光谱成像（“MRSI”），X射线诊断成像， 和超声成像。 公开了新颖的涂层和制造技术来控制颗粒尺寸和颗粒聚集，从而获得用于肝脏，脾脏或组织疾病状态的器官特异性成像的组合物。 根据诊断成像技术，含钙/含氧阴离子的颗粒被处理为顺磁性，不透射线的或回声的。 还公开了执行医学诊断程序的诊断组合物和方法，其涉及向温血动物施用诊断有效量的上述颗粒，然后进行医学诊断程序。

公开(公告)号：US5382388A

公开(公告)日：1995-01-17

申请号：US933385

申请日：1992-08-21

申请人： Gary J. Ehrhardt ,  Robert G. Wolfangel ,  Edward A. Deutsch

发明人： Gary J. Ehrhardt ,  Robert G. Wolfangel ,  Edward A. Deutsch

IPC分类号： C01G1/00 ,  C01G39/00 ,  C01G41/00 ,  G21G4/08 ,  C09K11/00 ,  B01J13/00 ,  C09K3/00

CPC分类号： G21G4/08

摘要： Process for preparing a radionuclide generator for producing Tc-99m or Re-188. A clear solution containing a metallic cation and an anion comprising W-188 or Mo-99 is provided. The metallic cation is present in the solution as a dissolved complex of the metallic cation and a complexing agent and/or the anion being present in the solution as a dissolved complex of the anion and a complexing agent. The dissolved complex(es) are decomposed to form a slurry containing a precipitate of the metallic cation and the anion. The precipitate is transferred to an elutable container of a radionuclide generator.

摘要翻译： 制备Tc-99m或Re-188的放射性核素发生器的方法。 提供了含有金属阳离子和包含W-188或Mo-99的阴离子的透明溶液。 金属阳离子作为金属阳离子和络合剂和/或阴离子的溶解络合物存在于溶液中，作为阴离子和络合剂的溶解络合物存在于溶液中。 溶解的复合物分解形成含有金属阳离子和阴离子沉淀物的浆料。 将沉淀物转移到放射性核素发生器的可洗涤容器中。

公开(公告)号：US4075314A

公开(公告)日：1978-02-21

申请号：US681626

申请日：1976-04-29

申请人： Robert G. Wolfangel ,  Howard A. Anderson

发明人： Robert G. Wolfangel ,  Howard A. Anderson

IPC分类号： A61K51/00 ,  A61K33/24 ,  A61K51/02 ,  A61K51/04 ,  A61K43/00 ,  A61K29/00

CPC分类号： A61K51/02 ,  A61K51/0489 ,  A61K2123/00

摘要： Improved stannous pyrophosphate technetium-99m compositions.

摘要翻译： 改进的焦磷酸亚铁锝-99m组合物。

公开(公告)号：US4057616A

公开(公告)日：1977-11-08

申请号：US629751

申请日：1975-11-07

申请人： Robert G. Wolfangel

发明人： Robert G. Wolfangel

IPC分类号： A61K51/12 ,  A61K43/00 ,  A61K29/00

CPC分类号： A61K51/1217 ,  A61K51/1251 ,  A61K2123/00

摘要： Metal hydroxides such as Fe(OH).sub.2, Fe(OH).sub.3 and Sn(OH).sub.2 are prepared in the form of spherical particles of uniform and controlled size suitable for tagging with a radioactive element such as technetium-99m. Aqueous suspensions of such tagged particles are useful in scintigraphy as lung scanning agents.

摘要翻译： 制备金属氢氧化物如Fe（OH）2，Fe（OH）3和Sn（OH）2，其形式为均匀和受控尺寸的球形颗粒，其适用于用诸如锝-99m的放射性元素进行标记。 这种标记的颗粒的水悬浮液可用作闪烁扫描作为肺扫描剂。

公开(公告)号：US5219556A

公开(公告)日：1993-06-15

申请号：US549981

申请日：1990-07-09

申请人： Robert G. Wolfangel

发明人： Robert G. Wolfangel

IPC分类号： A61K51/10 ,  A61K51/12

CPC分类号： A61K51/1093 ,  A61K51/1241 ,  A61K2121/00 ,  A61K2123/00

摘要： A method of preparing a stable, therapeutic radiopharmaceutical composition comprised of an alpha- or beta-emitting radionuclide and a ligand by lyophilizing a solution of the complex. The radionuclide preferably has a half-life of at least twelve hours. The invention also is directed to stable lyophilized radiopharmaceutical compositions prepared by this method. The invention is particularly suited to the preparation of radionuclide-labeled antibodies in a stable form which merely requires reconstitution at the point of use.

摘要翻译： 通过将复合物的溶液冻干来制备由α或β发射放射性核素和配体组成的稳定的治疗性放射性药物组合物的方法。 放射性核素优选具有至少12小时的半衰期。 本发明还涉及通过该方法制备的稳定的冻干放射性药物组合物。 本发明特别适用于以稳定形式制备放射性核素标记的抗体，其仅需要在使用时重建。